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Cardiovascular (CV) diseases are burdened by high mortality and morbidity, being re-
sponsible for half of the deaths in Europe. Although hypertension is recognized as
the most important CV risk factor, hypertension awareness and blood pressure (BP)
control are still unsatisfactory. In 2017, 30.6% of a >10 000 individual sample who
took part in the May Measurement Month (MMM) campaign in Italy was found to have
high BP. To raise awareness on the hypertension issue and to report BP data on a
nation-wide scale in Italy. In the frame of the MMM campaign, an opportunistic cross-
sectional survey of volunteers aged 18 was carried out in May 2018. Blood pressure
measurement, the definition of hypertension and statistical analysis followed the
standard MMM protocol. Screenings were conducted in multiple sites by health care
personnel. Among the 5554 people screened (females: 48.3%, mean age
586 17 years) mean BP was 127/77mmHg, and after imputations, 1462 (26.3%) par-
ticipants were found to have high BP levels. Body mass index >25 was associated
with higher systolic BP and diastolic BP (DBP), while diabetes was associated with
high DBP only. Our data provide a nation-wide snapshot of BP control in a sample of
individuals participating in a national health care campaign, and confirm the power
of this kind of healthcare-related activities in reaching a significant number of peo-
ple to raise awareness on health topics. The apparent positive trend in BP control
compared to available data from other similar campaigns carried out during the past
years needs to be confirmed with more methodologically robust studies.
Introduction
Cardiovascular (CV) diseases (CVDs) are responsible for
more than half of all deaths across Europe. Thanks to a
combination of modifiable and unmodifiable factors, in-
cluding but not limited to unhealthy lifestyle and improved
survival to acute events, their prevalence is on the rise.1
In 2016, the Italian Agency of Statistics (ISTAT) reported
a yearly incidence of 367 deaths due to CVDs per 100 000
inhabitants, corresponding to a total of approximately
220 200 deaths. Of these, 69 653 were due to ischaemic
heart disease, and 57 230 to cerebrovascular diseases.2
The effectiveness of total CV risk reduction in preventing
events is universally accepted3,4 and up to 80% of prema-
ture heart disease and stroke are considered preventable.5
Arterial hypertension, known as the silent killer, represents
the most important independent risk factor for CVDs,6 with
a reported prevalence in Italy ranging from 55% to 59% of
the adult population,7 with target blood pressure (BP) val-
ues reportedly achieved in <50% of known hypertensives.8
For this reason, the Italian Society of Hypertension has
been active over many years in raising awareness in both
the general population and health professionals on this is-
sue, taking part each year for more than a decade in the
World Hypertension Day activities, promoted by the World
Hypertension League/International Society of Hypertension.
On these bases, taking part in the May Measurement Month
(MMM) initiative9,10 was just the natural step forward, with
the aim of reaching as many people as possible and of stimu-
lating them to develop a more pro-active attitude towards
management of their cardiovascular risk profile, in particu-
lar in relation to their BP levels. In 2017, thanks to the
invaluable contribution of more than 300 investigators affili-
ated to the Italian Society of Hypertension and of the Italian
Red Cross, which supported the initiative with logistics and
personnel, we were able to reach more than 10 000 peo-
ple.11 In 2018, we decided to administer a more complete
questionnaire, collecting data on anthropometric variables
as well as on comorbidities, a choice which has allowed us to
obtain more comprehensive information, but a the price of
a lower number of subjects accepting to participate.
Methods
MMM18 activities in Italy were co-ordinated by the Council
of the Italian Society of Hypertension as in previous years.
Informed consent was obtained for each participant onsite.
No personal information was requested, as all forms were
anonymously filled in. During the month of May 2018, 91
sites in Italy operated for a different number of days (from
1 to 5days depending on the site), interviewing and mea-
suring the BP of individuals aged 18 and over who decided
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to stop by. A total estimated number of 200 volunteers
were involved in the campaign. Blood pressure measuring
stations were available inside hospitals and at crossroads,
with the logistical support of the Italian Red Cross, both in
cities and villages. All the staff had a training in health care
and received specific training on BP measurements. Either
doctors, nurses, paramedics, and medical students per-
formed the BP recordings and administered an ad hoc cre-
ated questionnaire. In addition, outdoormeasurements were
performed in walled gazebos, in order to keep the ambient
temperature controlled and to allow seated rest of suitable
duration before the measurement. All selected devices had
been validated accordingly to the ESH-IP protocol and BP
measurements were performed according to the European
Society of Hypertension/European Society of Cardiology
(ESH/ESC) 2018 guidelines. In brief, three consecutive meas-
urements were collected in the sitting position, with back
and arm supported, after a 5-min rest. Hypertension was de-
fined as BP >140/90mmHg (average of the 2nd and 3rd
measurements) and/or evidence of treatment with antihy-
pertensive medication. Furthermore, height and weight
reported by the participants were recorded, alongside with
the history of cardiovascular risk factors.
The study was bottom funded, i.e. each centre which de-
cided to take part in the activity printed its own question-
naires and BP forms and then sent the hard copies to the
core lab for data entry facilitated by optical character rec-
ognition technology. Data were centrally analysed by the
MMM team in London with multiple imputation according
to the standard analysis plan.9
Results
Our sample consisted of 5554 participants (females:
48.3%), aged 586 17 years. The absolute number of
participants per age groups increased by each decade after
39years old, reaching the maximum for the age group
>70years, which counted 1581 subjects, representing
28.5% of the whole sample.
Active smoking was reported by 825 subjects (14.9%), di-
abetes by 446 (8.0%), previous myocardial infarction by
399 (7.2%), and previous stroke by 122 (2.2%). Mean body
mass index was 25.46 4.4, with 47.3% of subjects being of
normal weight or underweight and 49.3% overweight or
obese (these data were not available in 3.4% of subjects).
Average BP (mean of reading 2 and 3) was 127/77mmHg,
with a proportion of hypertensives (as previously defined)
after imputation of 26.3% out of the 5554 subjects screened.
Known hypertension (N¼ 1692, 30.5%) was associated
with higher systolic BP (SBP) and diastolic BP (DBP) (P <
0.0001 for both), whilst diabetes was associated with
higher SBPonly. Furthermore, patients who reported a pre-
vious myocardial infarction had lower DBP (P¼ 0.026).
Accordingly, obesity (14%) and overweight (35.3%) status
were associated with higher SBP and DBP (P < 0.0001 for
all), whilst underweight status (2.8%) was associated with
lower SBP/DBP compared to normal weight (44.5%, P <
0.0001 for SBP, P¼ 0.002 for DBP) (see Figure 1).
Discussion
Our data, obtained through a cross-sectional survey, pro-
vide a contemporary update on BP values collected nation-
wide from a sample of the Italian population. As described,
26.3% of the screened individuals were found to be hyper-
tensive, a proportion slightly lower than the one reported
by our group in 2017 in the same frame of the MMM cam-
paign (30.8% out of a sample of>10 000 individuals),11 and
in 2015, in a similar campaign conducted during the World
Figure 1 Mean blood pressure values in those with different cardiovascular risk factors compared to those without, from linear regression models ad-
justed for age and sex.
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Hypertension Day (36% out of a sample of 8657 individu-
als).8 Similarly, the reported average BP values slightly but
progressively decreased from 2015 (133/80mmHg)8 to
2017 (130/78mmHg)11 to 2018 (127/77mmHg). Although
we recognize that the significance of these data, especially
in terms of comparability from 1 year to the other, is weak-
ened by a number of methodological limitations, typical of
the ‘street epidemiology’ approach (including but not lim-
ited to sampling bias, incomplete sample characterization,
environmental factors unaccountable for the lack of spe-
cific cut-off values for BPmeasured in such circumstances),
they still appear encouraging. In fact, over the years many
efforts have been made by the Italian Society of
Hypertension aimed at raising awareness of hypertension
and its complications,12 increasing early diagnosis and im-
proving BP control. These efforts now seem to yield appre-
ciable results. As per the other findings, they are generally
consistent with available literature, including the relation-
ship between body weight and BP, the increased preva-
lence of high BP values in diabetic patients, the gap
observed between females and males BP, which narrows as
age increases.3
By joining the MMM campaign, we have thus been able to
reach a significant number of people, to measure their BP
in a carefully standardized manner and to spread higher
awareness on hypertension and its untoward consequences
with the final goal of improving BP control (as shown by the
progressive reduction in the average BP levels we have
recorded over the years) which might help to reduce CV
morbidity andmortality.
Supplementary material
Supplementary material is available at European Heart
Journal Supplements online.
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